Clinical Trial Update: The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing the iRAMT protocol for tapering methotrexate in rheumatoid arthritis patients treated with infliximab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Remicade (infliximab)

Snippet

Sponsor: Centocor Ortho Biotech Services, L.L.C. | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED